The 30-day reduced exercise price window creates a near-term catalyst for massive warrant exercise and dilution. Monitor for a Form 4 filing from Streeterville Capital indicating exercise, and watch for the company's termination of the reduced price period. The stock is likely to face significant selling pressure as the warrant holder can immediately sell shares acquired at $1.50 into the market at the current price.
Price Chart
Executive Summary
AMASS Brands filed an 8-K and a 424B5 prospectus supplement on July 10, 2026, disclosing Amendment No. 3 to the Streeterville Capital warrant. The amendment temporarily reduces the warrant exercise price from $16.00 to $1.50 per share for a 30-day period, creating a massive incentive for immediate exercise and potential dilution of up to 14.3M shares. The 424B5 was filed simultaneously to satisfy the disclosure requirement of the warrant amendment, linking the capital raise structure directly to this dilutive event.
Key Facts
- AMASS Brands entered Amendment No. 3 to the Streeterville Capital warrant on July 10, 2026, reducing the exercise price to $1.50 per share for a 30-day period (from $16.00).
- The reduced exercise price of $1.50 is approximately 90% below the original $16.00 exercise price, creating a massive incentive for immediate exercise.
- The warrant is registered for resale of up to 14,293,298 shares of common stock, representing ~80% of the current 17.8M share count (based on $18M market cap / current price).
- The company may terminate the reduced exercise price period at any time upon 2 trading days' notice, giving it some control over the timing of dilution.
- The 424B5 prospectus supplement was filed simultaneously to satisfy the disclosure requirement of the warrant amendment, linking the capital raise structure directly to this dilutive event.
Financial Impact
Potential dilution of up to 14,293,298 shares (approximately 80% of current shares outstanding) at $1.50/share, representing a potential capital raise of ~$21.4M if fully exercised. The $1.50 exercise price is a ~90% discount to the $16.00 original exercise price.
Risk Factors
- Massive dilution of up to ~80% of current shares outstanding if the warrant is fully exercised at $1.50/share
- Streeterville Capital, a known distressed-debt investor, may immediately sell shares acquired at $1.50 into the market, creating sustained selling pressure
- The company can terminate the reduced price period on 2 days' notice, creating uncertainty about the exact timing and extent of dilution
- The $16.00 post-period exercise price is far above the current market price, making the warrant worthless after the 30-day window unless the stock appreciates dramatically
Market Snapshot
Documents Analyzed
This report is based on 14 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (AMSS) — Batch item 1 | 0001575872-26-000497 |
| Document: amass032_ex4-1.htm | 0001575872-26-000497 |
| Document: 0001575872-26-000497-index-headers.html | 0001575872-26-000498 |
| Document: 0001575872-26-000497-index.html | 0001575872-26-000497 |
| Document: 0001575872-26-000497.txt | 0001575872-26-000497 |
| 8-K Filing (AMSS) — Batch item 6 | 0001575872-26-000497 |
| Document: amass032_ex4-1.htm | 0001575872-26-000497 |
| Document: 0001575872-26-000497-index-headers.html | 0001575872-26-000497 |
| Document: 0001575872-26-000497-index.html | 0001575872-26-000497 |
| Document: 0001575872-26-000497.txt | 0001575872-26-000497 |
| 424B5 Filing (AMSS) — Batch item 11 | 0001575872-26-000498 |
| Document: 0001575872-26-000498-index-headers.html | 0001575872-26-000497 |
| Document: 0001575872-26-000498-index.html | 0001575872-26-000497 |
| Document: 0001575872-26-000498.txt | 0001575872-26-000497 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 424B5 | $0.3101 | awaiting T+60 | — | $0.3087 (+0.45%) |
Oct 26, 2026 1d ago | 424B5 | $0.3101 | awaiting T+60 | — | $0.3087 (+0.45%) |
Oct 23, 2026 4d ago | 8-K | $0.3101 | awaiting T+60 | — | $0.3087 (+0.45%) |
Oct 14, 2026 13d ago | 8-K | $0.3600 | awaiting T+60 | — | $0.3087 (+14.25%) |
Oct 6, 2026 21d ago | 8-K | $0.3900 | awaiting T+60 | — | $0.3087 (−20.85%) |
Sep 29, 2026 28d ago | Press Release | $0.4400 | awaiting T+60 | — | $0.3087 (−29.84%) |
Aug 17, 2026 10w ago | 8-K | $0.9500 | awaiting T+60 | — | $0.3087 (+67.51%) |
Aug 17, 2026 10w ago | Press Release | $0.9500 | awaiting T+60 | — | $0.3087 (−67.51%) |
Aug 5, 2026 11w ago | 8-K | $1.13 | awaiting T+60 | — | $0.3087 (+72.68%) |
Jul 10, 2026 15w ago | 8-K / 424B5 | $1.47 $0.4273 | ▲ +70.93% | ▲ +74.93% | $0.3087 (+79.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers